Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?

por Deberne, Mélanie, Ropert, Stanislas, Billemont, Bertrand, Daniel, Catherine, Chapron, Jeanne, Goldwasser, François
Publicado 2014

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors

por Brendel, Erich, Ludwig, Matthias, Lathia, Chetan, Robert, Caroline, Ropert, Stanislas, Soria, Jean-Charles, Armand, Jean-Pierre
Publicado 2010

Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study

por Coriat, Romain, Faivre, Sandrine J, Mir, Olivier, Dreyer, Chantal, Ropert, Stanislas, Bouattour, Mohammed, Desjardins, Robert, Goldwasser, François, Raymond, Eric
Publicado 2016

Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib

por Coriat, Romain, Gouya, Hervé, Mir, Olivier, Ropert, Stanislas, Vignaux, Olivier, Chaussade, Stanislas, Sogni, Philippe, Pol, Stanislas, Blanchet, Benoit, Legmann, Paul, Goldwasser, François
Publicado 2011

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

por Mir, Olivier, Coriat, Romain, Blanchet, Benoit, Durand, Jean-Philippe, Boudou-Rouquette, Pascaline, Michels, Judith, Ropert, Stanislas, Vidal, Michel, Pol, Stanislas, Chaussade, Stanislas, Goldwasser, François
Publicado 2012

Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study

por Watson, Sarah, Verret, Benjamin, Ropert, Stanislas, Adam, Julien, Bahleda, Rastislav, Briand, Sylvain, Cavalcanti, Andrea, Chamseddine, Ali N., Court, Charles, Fadel, Elie, Faron, Matthieu, Haddag‐Miliani, Leila, Henon, Clémence, Pechoux, Cécile Le, Levy, Antonin, Mercier, Olaf, Ngo, Carine, Honoré, Charles, Cesne, Axel Le, Mir, Olivier
Publicado 2022